Global Biologics Market Growth, Share - Industry Analysis Report 2025 - PowerPoint PPT Presentation

About This Presentation

Global Biologics Market Growth, Share - Industry Analysis Report 2025


Get to know about Biologics Market share, size, technology, trends & Forecasts done by Adroit Market Research for the year 2018-2025. – PowerPoint PPT presentation

Number of Views:88
Slides: 6
Provided by: Jocelynahardwick
Category: Other


Transcript and Presenter's Notes

Title: Global Biologics Market Growth, Share - Industry Analysis Report 2025

Global Biologics Market
  • Drivers, Restraints, Potential Growth
    Opportunities, Vendor Competitive Landscape,
    Trends and Forecast 2018-2025

Single Use License US 4800
Request Sample
Global Biologics Market Size and Share-Global
Forecast to 2025
  • The global biologics market 2017 was estimated to
    be USD xx Million. It is anticipated to increase
    to a value of USD xx Million with a CAGR of xx
    over the forecast period. Continuous activities
    in research and development, investment in
    biologics and occurrence of chronic diseases are
    the factors that are playing a major role in the
    growth of biologics market. As per WHO, chronic
    diseases will account for approximately 80 of
    death by 2020 across the world. Constant
    development in gene cellular therapy is
    catalyzing the market because of its therapeutic
    outcome and high efficiency. CAR-T-Cell are
    therapies recently accepted by FDA for the
    indications of oncology.
  • Read more details of the report at
  • Drugs are very complicated and need maintenance
    and controlled conditions for production and
    development processes. Huge finances are required
    to regulate the procedures of quality control
    initially. Biologics are prone to heat, light and
    require positive atmosphere which is not
    available worldwide. Strict rules and investment
    with restricted access to patient for biologics,
    particularly in emerging countries will affect
    the growth of global biologics market.
  • Biopharmaceuticals is getting popular over
    chemically synthesized molecules which are
    projected to increase the generation of revenue
    considerably. Moreover, by using the biologics
    many metabolic disorders can be treated to
    increase the demand of biologics market.
    Developed bioengineering technologies as well for
    the production of biopharmaceutical is estimated
    to fuel the pharmaceutical industry. With the
    advancements in automation, process of assortment
    can be done with the help of high throughput
    screening (HTS) system for the selection of

Global Biologics Market Size and Share-Global
Forecast to 2025
  • Biologics market trends are initiative by
    government to support biologic drugs that allow
    funding and investment in research and
    development eventually increasing the quality of
    biologic drugs. This will positively upsurge the
    demand for biologics market growth. Success rate
    of biologic drugs is increasing thus increasing
    the demand for manufacturing biologics amongst
    the big pharmaceutical companies. For example,
    Bristol-Myers Squibb capitalized about 800
    Million in Irish large-scale biologics facility
    and Novartis AG capitalized about 750 Million in
    biologics facility in Singapore estimating to
    complete the production by the end of 2019.
    Accepting innovative therapies and increase in
    chronic diseases are the factors that are fueling
    the growth of biologics market.
  • Global biologics market is segmented on the basis
    of application, source, type and region. Based on
    application, biologics market is divided into
    cancer, anemia, diabetes and many more. By
    source, market is divided into animal, human and
    microorganism. Based on type, biologics market is
    splited into blood products, gene therapy,
    vaccines, proteins, monoclonal antibodies and
    much more.
  • Topographically, regions involved in accelerating
    the biologics market share are Asia Pacific,
    Europe, U.S, South America, North America and
    Middle East Africa. U.S biologics market is
    dominating the market in North America with huge
    investment and research and development. Growth
    in the concerns and awareness regarding oncology
    and its treatment will help to surge the global
    biologics market in North America. Asia Pacific
    is propelled to expand rapidly due to less strict
    rules for the clinical trials of drugs,
    developing awareness of biologics for the
    treatment of chronic diseases and manufacturing
    of biologics in the developing countries.

Global Biologics Market Size and Share-Global
Forecast to 2025
  • By Application market is segmented into
  • Cancer
  • Anemia
  • Diabetes
  • Others
  • By Source market is segmented into
  • Animals
  • Humans
  • Microorganisms
  • By Type market is segmented into
  • Blood products
  • Gene therapy
  • Vaccines
  • Proteins
  • Monoclonal antibodies

About Us
  • Adroit Market Research is an India-based business
    analytics and consulting company. Our target
    audience is a wide range of corporations,
    manufacturing companies, product/technology
    development institutions and industry
    associations that require understanding of a
    markets size, key trends, participants and
    future outlook of an industry. We intend to
    become our clients knowledge partner and provide
    them with valuable market insights to help create
    opportunities that increase their revenues. We
    follow a code Explore, Learn and Transform. At
    our core, we are curious people who love to
    identify and understand industry patterns, create
    an insightful study around our findings and churn
    out money-making roadmaps. Our analysts have
    tracked high growth markets in chemicals
    materials, healthcare pharmaceuticals,
    semiconductor electronics, energy power, food
    retail, consumer goods, technology, and
    machinery equipment sectors across the world to
    identify new opportunities, potential customers,
    prepare go-to-market (GTM) strategies, identify
    segments for revenue growth for companies, and
    many more.
  • US Headquarters3131 McKinney Ave Ste 600
    Dallas, TX 75204 ,U.S.A 
  • Phone 1 (214) 884-6068
  • Email
Write a Comment
User Comments (0)